Update on Umbilical Cord Blood Transplantation

  • Karen Ballen
Part of the Contemporary Hematology book series (CH)


The initial observations on the potential of umbilical cord blood came from the laboratories of Broxmeyer, Knudtzon, Lansford, Metcalf and others, demonstrating that the cord blood contained a high percentage of granulocyte-macrophage progenitor cells [1-3]. These initial experiments led to work in a murine model, showing that neonatal mice contain sufficient progenitor cells that repopulate the lethally irradiated mice. Sufficient progenitor cells were also found in the human cord blood, and was used to promote engraftment, leading to the first successful cord blood transplant in 1988 [2, 4]. Further investigation, subsequent to the initial clinical studies, revealed the unique properties of umbilical cord blood grafts. CD34+ cord blood cells increase faster than adult bone marrow cells in culture, allowing a 10-fold lower CD34+ cell dose to be used in cord blood transplants [3, 5].


Cord Blood Peripheral Blood Stem Cell Cord Blood Transplantation Cord Blood Cell Neutrophil Engraftment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Knudtzon S (1974) In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 43:357-361PubMedGoogle Scholar
  2. 2.
    Broxmeyer HE, Kurtzberg J, Gluckman E et al (1991) Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 17:313-329PubMedGoogle Scholar
  3. 3.
    Lansdorp PM, Dragowska W, Mayani H (1993) Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787-791PubMedCrossRefGoogle Scholar
  4. 4.
    Gluckman E, Broxmeyer HA, Auerbach AD (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 321:1174-1178PubMedCrossRefGoogle Scholar
  5. 5.
    Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoeitic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860PubMedCrossRefGoogle Scholar
  6. 6.
    Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, Kurtzberg J (2003) Coexistant naïve phenotype and higher cycling rate of cord blood T cells compared to adult peripheral blood. Exp Hematol 31:708-714PubMedCrossRefGoogle Scholar
  7. 7.
    Kim YJ, Brutkiewicz PR, Broxmeyer HE (2002) Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells. Blood 100:3253-3260PubMedCrossRefGoogle Scholar
  8. 8.
    Berthou C, Legros-Maida S, Soulie A et al (2003) Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 102:4608CrossRefGoogle Scholar
  9. 9.
    Bone Marrow Donors Worldwide, Annual Report 2006Google Scholar
  10. 10.
    Smythe J, Armitage S, McDonald D, Pamphilon D, Guttridge M, Brown J et al (2007) Directed sibling cord blood banking for transplantation: The 10-year experience in the national blood service in england. Stem Cells 25:2087-2093PubMedCrossRefGoogle Scholar
  11. 11.
    Ballen KK, Kurtzberg J, Lane TA, Lindgren BR, Miller JP, Nagan D et al (2004) Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks. Biol Blood Marrow Transplant 10:269-275PubMedCrossRefGoogle Scholar
  12. 12.
    Cairo MS, Wagner EL, Fraser J et al (2005) Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: A cord blood transplantation (COBLT) study report. Transfusion 45:856-866PubMedCrossRefGoogle Scholar
  13. 13.
    Laskey LC, Lane TA, Miller JR, Lindgren B, Patterson H, Haley NR et al (2002) In utero or ex utero cord blood collection: Which is better?. Transfusion 42:1261-1267CrossRefGoogle Scholar
  14. 14.
    Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing TH, Graham ML (2007) Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced. Biol Blood Marrow Transplant 13:1346-1357PubMedCrossRefGoogle Scholar
  15. 15.
    Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ (2002) Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8:257-260PubMedCrossRefGoogle Scholar
  16. 16.
    Atlas LD (2006) The national marrow donor program in 2006: Constants and challenges. Transfusion 46:1080-1084PubMedCrossRefGoogle Scholar
  17. 17.
    American Academy of Pediatrics Section of Hematology/Oncology (2007) Cord blood banking for potential future transplantation. Pediatrics 119:165-170CrossRefGoogle Scholar
  18. 18.
    American College of Obstetricians and Gynecology (1997) Routine storage of umbilical cord blood for potential future transplantation. ACOG Comm Opin 183:1-3Google Scholar
  19. 19.
    Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:356-363PubMedCrossRefGoogle Scholar
  20. 20.
    Gluckman E, Auerbach BHA, AD FHS, Douglas GW, Devergie A et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178PubMedCrossRefGoogle Scholar
  21. 21.
    Locatelli F, Rocha V, Chastang C et al (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia: Eurocord-cord blood transplant group. Blood 93:3662-3671PubMedGoogle Scholar
  22. 22.
    Locatelli F, Rocha V, Reed W et al (2003) Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101:2137-2143PubMedCrossRefGoogle Scholar
  23. 23.
    Kurtzberg J, Laughlin M, Graham ML et al (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157-166PubMedCrossRefGoogle Scholar
  24. 24.
    Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: A comparison study. Lancet 369:1947-1954PubMedCrossRefGoogle Scholar
  25. 25.
    Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Lim YC (2007) A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrrow Transplant 13:444-453CrossRefGoogle Scholar
  26. 26.
    Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 350:1960-1969PubMedCrossRefGoogle Scholar
  27. 27.
    Escolar ML, Poe MD, Provenzale JM et al (2005) Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N Engl J Med 352:2069-2081PubMedCrossRefGoogle Scholar
  28. 28.
    Kobayashi R, Ariga T, Nonoyama S et al (2006) Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: An analysis of 57 patients in Japan. Br J Hematol 135:362-366CrossRefGoogle Scholar
  29. 29.
    Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al (2007) Results of unrelated cord blood transplant in Fanconi anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 13:1073-1082PubMedCrossRefGoogle Scholar
  30. 30.
    Wall DA, Chan KW (2008) Selection of cord blood unit (s) for transplantation. Bone Marrow Transplant 42:1-7PubMedCrossRefGoogle Scholar
  31. 31.
    Laughlin MJ, Barker J, Bambach B et al (2001) Hematpoietic engraftment and survival in adult recipients on umbilical-cord blood from unrelated donors. N Engl J Med 344:1815-1822PubMedCrossRefGoogle Scholar
  32. 32.
    Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in patients with leukemia. N Engl J Med 351:2265-2275PubMedCrossRefGoogle Scholar
  33. 33.
    Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al (2004) Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285PubMedCrossRefGoogle Scholar
  34. 34.
    Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Monna MO et al (2007) Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109:1322-1330PubMedCrossRefGoogle Scholar
  35. 35.
    Khouri IF, Saliba RM, Giralt SA et al (2001) Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft vs host disease, and treatment-related mortality. Blood 98:3595-3599PubMedCrossRefGoogle Scholar
  36. 36.
    Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B et al (2003) Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol Blood Marrow Transplant 9:373-382PubMedCrossRefGoogle Scholar
  37. 37.
    Yuji K, Miyakoshi S, Kato D et al (2005) Reduced-intensity unrelated cord blood transplantation for patients with advanced lymphoma. Biol Blood Marrow Transplant 11:314-318PubMedCrossRefGoogle Scholar
  38. 38.
    Miyakoshi S, Kami M, Tanimoto T, Yamguchi T, Narimatsu H, Kusumi E et al (2007) Tacrolimus as prophylaxis for acute graft versus host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. Transplantation 84:316-322PubMedCrossRefGoogle Scholar
  39. 39.
    Chao NJ, Koh LP, Long GD et al (2004) Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 10:569-575PubMedCrossRefGoogle Scholar
  40. 40.
    Barker JN, Weisdorf DJ, Defor TE, Blazar BR, McGlave PB, Miller JS et al (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343-1347PubMedCrossRefGoogle Scholar
  41. 41.
    Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact of transplantation outcomes in 110 adults with hematologic disease. Blood 110:3064-3070PubMedCrossRefGoogle Scholar
  42. 42.
    Cutler C, Mitrovich R, Kao G, Ho V, Alyea E, Koreth J et al (2007) Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Blood 118:600a AbstractGoogle Scholar
  43. 43.
    Ballen KK, Spitzer TR, Yeap B, McAfee S, Dey BR, Attar E et al (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13:82-89PubMedCrossRefGoogle Scholar
  44. 44.
    Haspel RL, Kao G, Yeap BY, Cutler C, Soiffer RJ, Alyea EP et al (2008) Pre-infusion variables predict the predominant unit in the setting of reduced intensity double cord blood transplantation. Bone Marrow Transplant 41:523-529PubMedCrossRefGoogle Scholar
  45. 45.
    Verneris MR, Brunstein C, DeFor TE, Barker J, Weisdorf DJ, Blazar BR et al (2005) Risk of relapse after umbilical cord blood transplantation in patients with acute leukemia: Marked reduction in recipients of two units. Blood 106:305a AbstractGoogle Scholar
  46. 46.
    Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB et al (2002) Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8:368-376PubMedCrossRefGoogle Scholar
  47. 47.
    Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ (2007) Ex vivo expansion of umbilical cord blood stem cells for transplantation: Growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39:11-23PubMedCrossRefGoogle Scholar
  48. 48.
    Delaney C, Varnum-Finney B, Aoyama K, Brashem-Stein C, Bernstein ID (2005) Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106:2693-2699PubMedCrossRefGoogle Scholar
  49. 49.
    Shpall EJ, De Lima M, McManis JD, Robinson S, McNiece IK, Champlin RE (2005) Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 11:932-935CrossRefGoogle Scholar
  50. 50.
    Magro E, Regidor C, Cabrera R, Sanjuan I, Fores R, Garcia-Marco JA et al (2006) Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Hematologica 91:640-648Google Scholar
  51. 51.
    Safdar A, Rodriguez G, DeLima M, Petropoulos D, Chemaly R, Worth L et al (2007) Infections in 100 cord blood transplantations: Spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine 86:324-333PubMedCrossRefGoogle Scholar
  52. 52.
    Miyakoshi S, Kusumi E, Matsumura T, Hori A, Murashige N, Hamaki T et al (2007) Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biol Blood Marrow Transplant 13:771-777PubMedCrossRefGoogle Scholar
  53. 53.
    Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA (2001) Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581-588PubMedCrossRefGoogle Scholar
  54. 54.
    Vendrame M, Cassady J, Newcomb J et al (2004) Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390-2395PubMedCrossRefGoogle Scholar
  55. 55.
    Viener HL, Brusko T, Wasserfall C et al (2007) Changes in regulatory T cells following autologous umbilical cord blood transfusion in children with type I diabetes. J Am Diab Assoc 7:0314 AbstractGoogle Scholar
  56. 56.
    Ma N, Stamm C, Kaminski A et al (2005) Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 5:45-54CrossRefGoogle Scholar
  57. 57.
    Prat-Vidal C, Roura S, Farre J, Galvez C, Llach A, Molina CE et al (2007) Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant Proc 39:2434-2437PubMedCrossRefGoogle Scholar
  58. 58.
    Wu KH, Zhou B, Yu CT, Cui B, Lu SH, Han ZC, Liu Y (2007) Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 83:1491-1500PubMedCrossRefGoogle Scholar
  59. 59.
    Wagner JE, Barker JN, DeFor TE et al (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity n treatment-related mortality and survival. Blood 100:1611-1618PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Karen Ballen
    • 1
  1. 1.Division of Hematology/Oncology, Department of MedicineMassachusetts General HospitalBostonUSA

Personalised recommendations